{"product_id":"iladatuzumab-vedotin","title":"Iladatuzumab Vedotin","description":"\u003cp\u003e\u003cstrong\u003eIladatuzumab Vedotin\u003c\/strong\u003e is an antibody-drug conjugate (ADC) composed of CD79B (immunoglobulin-associated CD79 beta) antibody and cytotoxic agent monomethyl auristatin E (MMAE) conjugated through maleimidocaproyl-valyl-citrullinyl-p-aminobenzyloxycarbonyl (mc-val-cit-PABC) type linker.\u003c\/p\u003e\u003ch2\u003eProduct overview\u003c\/h2\u003e\u003cp\u003eIladatuzumab vedotin has the potential for B-cell non-Hodgkin lymphoma (B-NHL) research. The product background identifies the antibody component, target antigen and payload or linker architecture where these details are supplied. This ADC context supports comparison of antigen recognition, payload conjugation and cellular uptake behavior in controlled assay systems, especially when researchers need to distinguish conjugated biologics from unconjugated antibodies or standalone small molecules.\u003c\/p\u003e\u003ch2\u003eLaboratory context\u003c\/h2\u003e\u003cp\u003eThe listed workflow context supports binding and uptake-oriented laboratory studies where a defined antibody component, cellular target and conjugated payload are relevant to assay planning, including cell-surface binding, cell-uptake and protein-binding experiments, within oncology research.\u003c\/p\u003e","brand":"Selleck Chemicals","offers":[{"title":"1 mg","offer_id":58188061147481,"sku":"D4016-1MG","price":953.0,"currency_code":"EUR","in_stock":true},{"title":"5 × 1 mg","offer_id":58188061180249,"sku":"D4016-5X1MG","price":2918.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0923\/1011\/0553\/files\/a2-serial-chemical-structure_2ec5af8b-a7e4-4126-b598-f0f9e255a291.gif?v=1780390080","url":"https:\/\/absource.de\/products\/iladatuzumab-vedotin","provider":"Absource Diagnostics","version":"1.0","type":"link"}